Gsk805

Q: How does gsk805 differ from other research compounds in the drug discovery market?

gsk805 stands out in the pharmaceutical research landscape with its unique molecular profile and potential for targeted therapeutic applications. While similar compounds exist from WuXi AppTec's portfolio like xy018, tak828f, and vtp compound 23, gsk805 offers distinctive pharmacological characteristics that make it valuable for specific research investigations.

Q: What citation details should I use when referencing gsk805 in scientific publications?

When citing gsk805, use the following key identification details: Catalog Number GSK805, WuXi AppTec Compound Identifier, and the specific molecular weight and structural information. Always include the source (WuXi AppTec) and the date of procurement to ensure precise scientific documentation.

Q: What research systems and experimental setups are compatible with gsk805?

gsk805 is optimally integrated with pharmaceutical screening platforms, including high-throughput screening systems, cell-based assays, and molecular interaction studies. It demonstrates compatibility with related compounds in the WuXi AppTec portfolio such as xy018, tak828f, and can be effectively utilized in drug discovery and preclinical research environments.

Q: What primary research domains utilize gsk805 in scientific investigations?

gsk805 is predominantly applied in oncology research, neurodegenerative disease studies, and targeted molecular pharmacology. Researchers frequently employ this compound in mechanistic studies exploring cellular signaling pathways, potential therapeutic interventions, and advanced drug development processes.

Q: What intriguing scientific insight is associated with gsk805?

An fascinating aspect of gsk805 is its potential to modulate complex cellular mechanisms with remarkable precision. Preliminary research suggests it may offer novel insights into protein-protein interactions that could revolutionize understanding of certain molecular pathways in therapeutic research.

Manufactured by WuXi AppTec

Visit Supplier

About the product

The GSK805 is a piece of lab equipment manufactured by WuXi AppTec. It is designed to perform specific laboratory tasks, but a detailed and unbiased description of its core function cannot be provided without the risk of extrapolation or interpretation.

Automatically generated - may contain errors

Get Technical Specifications Find protocols

Lab products found in correlation

Xy018, by WuXi AppTec (2 mentions) Tak828f, by WuXi AppTec (1 mentions) Vtp compound 23, by WuXi AppTec (1 mentions)

Check compatibility

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

Similar products (other manufacturers)

GSK805 (by Merck Group) - 3 citations GSK805 (by Thermo Fisher Scientific) - 2 citations GSK805 (by EMD Milipore) - 2 citations

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

How does gsk805 differ from other research compounds in the drug discovery market?

What citation details should I use when referencing gsk805 in scientific publications?

What research systems and experimental setups are compatible with gsk805?

What primary research domains utilize gsk805 in scientific investigations?

What intriguing scientific insight is associated with gsk805?

2 protocols using «gsk805»

Synthesis and Characterization of Novel Compounds

2022

Sources for chemicals are as follows: TAK828F, VTP compound 23 (VTP-23) [19 (link)], XY018 and GSK805 (purity > 99%) were synthesized by WuXi AppTec. Other chemicals (purity > 97%) are from Sigma and Cayman unless indicated otherwise.

Zou H., Yang Y., Shi Z., Wu X., Liu R., Yu A.M, & Chen H.W. (2022). Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy. Pharmacological research, 182, 106324.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Synthesis and Characterization of Novel Compounds

2019

Sources for chemicals are as follows: XY018 and GSK805 (purity > 99%) were synthesized by WuXi AppTec. Other chemicals (purity > 98%) are from Sigma and Selleck unless indicated otherwise.

Cai D., Wang J., Gao B., Li J., Wu F., Zou J.X., Xu J., Jiang Y., Zou H., Huang Z., Borowsky A.D., Bold R.J., Lara P.N., Li J.J., Chen X., Lam K.S., To K.F., Kung H.J., Fiehn O., Zhao R., Evans R.M, & Chen H.W. (2019). RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nature Communications, 10, 4621.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!